arcellx.comHealthcareFounded: 2014Funding to Date: $235.48MM
Arcellx develops novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases.
For more details on financing and valuation for Arcellx, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
View Enterprise Value for Arcellx.
To read this article and more news on Arcellx, register or login.
